Blood Collection Devices Market

The global blood collection devices market is projected to reach USD 13.02 billion by 2030 from USD 9.13 billion in 2025, at a CAGR of 7.4% during the forecast period. Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors. The growth of the blood collection devices market is driven by the rising prevalence of infectious, chronic, and lifestyle-related diseases that necessitate frequent blood testing for diagnosis and monitoring. Additionally, the increasing number of hospitals, surgical centers, and trauma cases has boosted the demand for efficient and safe blood collection solutions. Moreover, growing awareness of blood donations and the expanding use of blood components in medical treatments further contribute to market expansion.

In January 2025, Terumo BCT, Inc. (Japan) signed a Memorandum of Understanding (MoU) on a strategic partnership with the Shandong Institute of Medical Devices and Pharmaceutical Packaging Inspection. This partnership will strengthen technical research and innovation, with emphasis on Terumo BCT's strategic product areas, including blood component collection.

In December 2024, Becton, Dickinson and Company (US), along with Babson Diagnostics, launched the BD MiniDraw Capillary Blood Collection System, which incorporates Babson's BetterWay technologies to enable test results from as few as six drops of capillary blood collected from a patient's finger.

The key players in this market are Fresenius Kabi AG (Germany), Becton, Dickinson and Company (US), Terumo BCT, Inc. (US), Grifols, S.A. (Spain), Nipro Medical Corporation (Japan), SARSTEDT AG & Co. KG (Germany), Haemonetics Corporation (US), Greiner Bio-One (Austria), and ICU Medical, Inc. (US), among others. Players in this market focused on partnerships, collaborations, agreements, acquisitions, mergers, expansions, and product launches & approvals to expand their market presence between January 2022 and August 2025.

To know about the assumptions considered for the study download the pdf brochure

FRESENIUS KABI AG (GERMANY)

Fresenius Kabi AG is the largest player in the blood collection devices market. The company offers a broad range of blood collection products, especially blood bags. It has maintained its market position by achieving a high level of customer satisfaction and strong brand equity. Over the years, Fresenius has built a robust product portfolio and a reliable distribution network that can reach the majority of its potential market. In recent years, the company has strengthened its leadership in the blood bags and consumables segment, with increasing focus on automation and sustainability initiatives in manufacturing. Fresenius is also actively expanding its footprint in the Asia Pacific and Latin America, where growing healthcare infrastructure and rising blood donation programs are creating new opportunities.

BECTON, DICKINSON AND COMPANY (US)

BD is the second-largest player in the global blood collection devices market and offers one of the broadest portfolios, including blood collection tubes, needles, syringes, blood bag sets, and lancets. The company has established itself strongly through its flagship Vacutainer system and is now diversifying into capillary blood collection technologies. In December 2023, BD received FDA clearance for a fingerstick device that provides laboratory-quality results at the point of care, and its BD MiniDraw system, developed with Babson Diagnostics, is being deployed in US pharmacies to make blood testing more accessible. BD continues to focus on patient comfort, less-invasive sampling methods, and digital health integration, while leveraging its strong presence in North America and Europe to accelerate expansion across high-growth Asia Pacific markets.

TERUMO BCT, INC. (JAPAN)

Terumo BCT, Inc. is the third-largest company in the market and is recognized for its broad range of blood collection products, particularly its apheresis systems. The company has developed a strong product and technology platform dedicated to blood collection devices, with long-term strategies focused on automation and emerging market penetration. In 2024, Terumo launched the Intercept 10 Platelet System, an advanced plateletpheresis technology that enhances efficiency and safety. The company has also expanded its manufacturing operations in the US and Costa Rica to reinforce supply chain resilience. It is also investing in digital integration platforms for blood management and expanding into cell-based therapies, positioning itself as a technology-driven leader in both mature and emerging markets.

Market Ranking

The top five players in the blood collection devices market are Fresenius Kabi AG (Germany), Becton, Dickinson and Company (BD) (US), Terumo BCT, Inc. (US), Greiner Bio-One (Austria), and Cardinal Health (US). These companies lead the market through strong product innovation, global distribution networks, and comprehensive portfolios catering to both manual and automated blood collection needs.

Fresenius Kabi holds a prominent position with its advanced whole-blood and apheresis collection systems that enhance donor safety and collection efficiency. BD dominates through its extensive range of blood collection tubes, needles, and safety-engineered devices widely adopted across hospitals and diagnostic laboratories. Terumo BCT drives growth with its cutting-edge blood component technologies and integrated collection systems. Greiner Bio-One contributes with its high-quality VACUETTE blood collection products that ensure sample integrity and compatibility with automated analyzers. Cardinal Health strengthens its position through a wide range of medical and laboratory supplies, supported by an extensive distribution infrastructure and customer-focused service network.

Related Reports:

Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com